Bayer plans blood glucose monitor costing less than INR 1000
In a bid to strengthen its presence in the diabetes care market, German healthcare major Bayer is planning to roll out a India-specific blood glucose monitor. The company intends to target the tier II and III markets with this device which is likely to be priced at below INR 1,000.
